# SPEVIGO

NDC: 50222-360
Generic name: spesolimab
Labeler / Manufacturer: LEO Pharma Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20260309

FDA application: BLA761244

## Active ingredients

- SPESOLIMAB: 60 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50222-360"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50222-360
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=78a4f7eb-8d34-4467-8d40-74ed24323806